KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) FCF Margin (2016 - 2025)

Amgen has reported FCF Margin over the past 17 years, most recently at 9.74% for Q4 2025.

  • Quarterly results put FCF Margin at 9.74% for Q4 2025, down 3869.0% from a year ago — trailing twelve months through Dec 2025 was 22.04% (down 906.0% YoY), and the annual figure for FY2025 was 22.04%, down 906.0%.
  • FCF Margin for Q4 2025 was 9.74% at Amgen, down from 44.45% in the prior quarter.
  • Over the last five years, FCF Margin for AMGN hit a ceiling of 503.05% in Q4 2022 and a floor of 3.53% in Q4 2023.
  • Median FCF Margin over the past 5 years was 32.05% (2021), compared with a mean of 52.26%.
  • Biggest five-year swings in FCF Margin: soared 46623bps in 2022 and later plummeted -49952bps in 2023.
  • Amgen's FCF Margin stood at 36.82% in 2021, then soared by 1266bps to 503.05% in 2022, then plummeted by -99bps to 3.53% in 2023, then skyrocketed by 1273bps to 48.43% in 2024, then tumbled by -80bps to 9.74% in 2025.
  • The last three reported values for FCF Margin were 9.74% (Q4 2025), 44.45% (Q3 2025), and 20.82% (Q2 2025) per Business Quant data.